1.5 Abstract in Rivista: [1819] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 1.819
Titolo Data di pubblicazione Autore(i) File
DIFFERENT EXPRESSION OF BRCA1 STATUS AND CLINICAL VARIABLES IN A SAMPLE OF ITALIAN WOMEN WITH EARLY ONSET BREAST CANCER (EOBC) 1-gen-2004 Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Capelletti, M; Neri, Tm; Savi, M; Bandini, N; Franciosi, V; De Lisi, V; Sgargi, P; Ardizzoni, A; Cascinu, S
Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC) 1-gen-2004 Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Capelletti, M; Bandini, N; Franciosi, V
BRCA1 and BRCA2 status in a sample of Italian women with early onset breast cancer (EOBC) 1-gen-2005 Bella, Ma; Michiara, M; Musolino, A; Naldi, N; Zanelli, P; Bortesi, B; Cappelletti, M; Neri, Tm; Savi, M; Bandini, N; De Lisi, V; Sgargi, P; Ardizzoni, A
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 1-gen-2006 Musolino, A; Naldi, N; Bortesi, B; Capelletti, M; Pezzuolo, D; Franciosi, D; Missale, G; Laccabue, D; Camisa, R; Ardizzoni, A
Brain metastasis (BM) prediction by transcriptomic profiling in triple-negative breast cancer (TNBC) 1-gen-2016 Duchnowska, Renata; Jarzab, Michal; Zebracka, Jadwiga; Matkowski, Rafal; Kowalczyk, Anna; Radecka, Barbara; Foszczynska-Kloda, Malgorzata; Musolino, Antonino; Czartoryska-Arlukowicz, Bogumila; Litwiniuk, Maria Malgorzata; Szablowska-Siwik, Sylwia; Karczmarek-Borowska, Bozenna; Sosinska-Mielcarek, Katarzyna; Chmielowska, Ewa; Olszewski, Wojciech P; Patera, Janusz; Zawrocki, Anton; Rusinek, Dagmara; Jassem, Jacek; Biernat, Wojciech
Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study 1-gen-2016 Musolino, A; Sikokis, A; Boggiani, D; Rimanti, A; Pellegrino, B; Silini, Em; Campanini, N; Barbieri, E; Cortesi, L; Panebianco, M; Porzio, R; Frassoldati, A; Sgargi, P; Falcini, F; Michiara, M
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 1-gen-2017 Migliari, S; Sammartano, A; Pellegrino, B; Regina, V; Cavazzini, D; Ottonello, S; Missale, G; Musolino, A; Ruffini, L
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 1-gen-2017 Conte, Pier Franco; Bisagni, Giancarlo; Frassoldati, Antonio; Brandes, Alba Ariela; Anselmi, Elisa; Giotta, Francesco; Aieta, Michele; Gebbia, Vittorio; Musolino, Antonino; Garrone, Ornella; Taverniti, Cristiana; Cavazzini, Giovanna; Turletti, Anna; Rubino, Daniela; Picardo, Elisa; Ferro, Antonella; Piacentini, Federico; Balduzzi, Sara; D'Amico, Roberto; Guarneri, Valentina
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer: ERIGE trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 1-gen-2017 Musolino, Antonino; Porzio, Rosa; Rubino, Daniela; Frassoldati, Antonio; Caldara, Alessia; Schirone, Alessio; Gori, Stefania; Piacentini, Federico; Berardi, Rossana; Brandes, Alba Ariela; Cavazzini, Giovanna; Foglietta, Jennifer; Villa, Federica; Pellegrino, Benedetta; Camisa, Roberta; Todeschini, Renata; Tognetto, Michele; Naldi, Nadia; Baldari, Daniela; Montemurro, Filippo
Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 1-gen-2017 Conte, P.; Conte, P.; Bisagni, G.; Frassoldati, A.; Brandes, A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Musolino, A.; Garrone, O.; Donadio, M.; Cavazzini, G.; Turletti, A.; Zamagni, C.; Danese, S.; Ferro, A.; Piacentini, F.; Balduzzi, S.; D'Amico, R.; Guarneri, V.
Abstract OT1-03-03: Phase II, open label, randomized, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with operable or locally advanced/Inflammatory HER2-positive breast cancer. ImmunHER trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 1-gen-2018 Musolino, A; Gori, S; Cavanna, L; Graiff, C; Frassoldati, A; Bria, E; Bisagni, G; Zambelli, A; Partesotti, G; Brandes, A; Bonetti, A; Moscetti, L; Zamagni, C; Rocca, A; Generali, D; Montemurro, F; Gianni, L; Tognetto, M; Maglietta, G; Todeschini, R
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 1-gen-2018 Conte, P. F.; Guarneri, V.; Bisagni, G.; Piacentini, F.; Brandes, A. A.; Cavanna, L.; Giotta, F.; Aieta, M.; Gebbia, V.; Frassoldati, A.; Musolino, A.; Garrone, O.; Taverniti, C.; Rimanti, A.; Sarti, S.; Rubino, D.; Bologna, A.; Vicini, R.; Balduzzi, S.; D'Amico, R.
Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial 1-gen-2018 Dieci, M. V.; Conte, P. F.; Bisagni, G.; Brandes, A. A.; Frassoldati, A.; Cavanna, L.; Musolino, A.; Giotta, F.; Rimanti, A.; Garrone, O.; Bertone, E.; Cagossi, K.; Sarti, S.; Ferro, A.; Omarini, C.; Maiorana, A.; Orvieto, E.; Sanders, M.; D'Amico, R.; Guarneri, V.
Abstract P1-14-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE Trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 1-gen-2019 Musolino, A; Cavanna, L; Boggiani, D; Zamagni, C; Frassoldati, A; Caldara, A; Rocca, A; Gori, S; Piacentini, F; Berardi, R; Brandes, Aa; Foglietta, J; Villa, F; Pellegrino, B; Todeschini, R; Tognetto, M; Naldi, N; Bortesi, B; Boni, L; Montemurro, F; Ardizzoni, A
SOPHIA primary analysis: A phase 3 (P3) study of margetuximab (M) + chemotherapy (C) versus trastuzumab (T) + C in patients (pts) with HER2+ metastatic (met) breast cancer (MBC) after prior anti-HER2 therapies (Tx) 1-gen-2019 Rugo, Hope S.; Im, Seock-Ah; Wright, Gail Lynn Shaw; Escriva-de-Romani, Santiago; Delaurentiis, Michelino; Cortes, Javier; Bahadur, Shakeela Wazeen; Haley, Barbara B.; Oyola, Raul H.; Riseberg, David A.; Musolino, Antonino; Cardoso, Fatima; Curigliano, Giuseppe; Kaufman, Peter A.; Pegram, Mark D.; Edlich, Sutton; Hong, Sam; Rock, Edwin P.; Gradishar, William John
PAM50 HER2-enriched subtype as an independent prognostic factor in early-stage HER2+ breast cancer following adjuvant chemotherapy plus trastuzumab in the ShortHER trial 1-gen-2019 Conte, Pier Franco; Griguolo, Gaia; Dieci, Maria Vittoria; Bisagni, Giancarlo; Brandes, Alba Ariela; Frassoldati, Antonio; Cavanna, Luigi; Musolino, Antonino; Giotta, Francesco; Rimanti, Anita; Garrone, Ornella; Galvan, Patricia; Brasó Maristany, Fara; Orvieto, Enrico; Urso, Loredana; Maiorana, Antonino; Balduzzi, Sara; D'Amico, Roberto; Guarneri, Valentina; Prat, Aleix
PARP inhibition increases immune infiltration in homologous recombination repair (HRR)-deficient tumors 1-gen-2019 Pellegrino, B.; Llop-Guevara, A.; Pedretti, F.; Cruz, C.; Castroviejo, M.; Cedro-Tanda, A.; Fasani, R.; Mateo, F.; Musolino, A.; Pujana, M. A.; Nuciforo, P. G.; Gros, A.; Balmana, J.; O’Connor, M. J.; Serra Elizalde, V.
522 POSTER Immunoglobulin G fragment C receptor polymorphisms and clinical outcome of EGFR-expressing metastatic colorectal cancer patients treated with cetuximab-based therapy 1-gen-2007 Negri, F.; Musolino, A.; Naldi, N.; Bortesi, B.; Boni, C.; Bisagni, G.; Camisa, R.; Ardizzoni, A.
HER2/NEU AMPLIFICATION IN FINE NEEDLE ASPIRATES FROM PRIMARY BREAST CANCER: IS IT A PREDICTIVE MARKER IN PATIENTS TREATED WITH NEOADJUVANT ANTHRACYCLINE BASED CHEMOTHERAPY? 1-gen-2004 Bozzetti, ; C, (Bozzetti; Cecilia), ; Musolino, A; Personeni, ; N, (Personeni; Nicola);, Nizzoli; R, (Nizzoli; Rita);, Michiara; M, (Michiara; Maria); Di, Blasio; B (Di, Blasio; Beatrice);, Ceci; G, (Ceci; Guido);, Camisa; R, (Camisa; Roberta);, Cascinu; S, (Cascinu; Stefano);, Ardizzoni; A, (Ardizzoni; Andrea),
Phase II Study of Bevacizumab in Combination with Docetaxel and Capecitabine for the First Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer 1-gen-2010 Musolino, A; Bisagni, ; G, (Bisagni; G., ); De Matteis; A (De, Matteis; A., ); Nuzzo; F, (Nuzzo; F., ); Ardizzoni; A, (Ardizzoni; A., ); Crino; L, (Crino; L., ); Gamucci; T, (Gamucci; T., ); Passalacqua; R, (Passalacqua; R., ); Gnoni; R, (Gnoni; R., ); Boni; C, (Boni; C., ).
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 621 a 640 di 1.819
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Articolo su rivista1819
Autore
  • DI MARIO, Francesco242
  • BUTI, Sebastiano150
  • GIULIANI, Nicola130
  • ALBERTINI, Roberto87
  • SEBASTIANI, MARCO85
  • SCARPIGNATO, Carmelo75
  • AGNETTI, Aldo66
  • PARRINO, Liborio66
  • MUSOLINO, Antonino61
  • CARANO, Nicola60
Data di pubblicazione
  • 2020 - 2026208
  • 2010 - 2019847
  • 2000 - 2009537
  • 1990 - 1999175
  • 1980 - 198951
  • 1979 - 19791
Editore
  • ELSEVIER25
  • Elsevier17
  • SAGE PUBLICATIONS LTD17
  • DIKE GIURIDICA15
  • ASCO pubs11
  • ELSEVIER IRELAND LTD7
  • ASCO6
  • ELSEVIER SCIENCE INC5
  • SAGE5
  • SPRINGERNATURE4
Rivista
  • DIGESTIVE AND LIVER DISEASE101
  • GASTROENTEROLOGY100
  • ANNALS OF ONCOLOGY94
  • BLOOD91
  • HAEMATOLOGICA59
  • JOURNAL OF CLINICAL ONCOLOGY58
  • NEUROLOGICAL SCIENCES47
  • UNITED EUROPEAN GASTROENTEROLOGY ...46
  • ANNALS OF THE RHEUMATIC DISEASES36
  • EPILEPSIA26
Keyword
  • Helicobacter pylori10
  • epilepsy9
  • sclerosi sistemica6
  • Bioengineering5
  • Gastroenterology5
  • HCV5
  • temporal lobe epilepsy5
  • UV5
  • GERD4
  • Lungs4
Lingua
  • eng969
  • ita176
  • fre1
Accesso al fulltext
  • no fulltext1787
  • reserved26
  • open6